Tag: Weight Loss Surgery and Bariatric
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity
Metabolic-Bariatric Surgery Tied to Reduced Risk for Pancreatic Cancer in Those With Obesity
Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D
Metabolic Surgery Is Renoprotective in Patients With Obesity, CKD
Metabolic surgery linked to lower risk for progression of kidney impairment compared with GLP-1RA
Weight-Loss Surgery Benefits Blood Pressure Management
Benefits include remission and control of hypertension while cutting dependence on antihypertensive medications
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group
Multimodal Antiobesity Medications Yield Superior Preoperative Weight Loss
Findings seen in high-risk patients with body mass index ≥70 preparing to undergo metabolic surgery
Bariatric Surgery Cuts Conversion to Diabetes Over Long-Term Follow-Up
Findings seen at five, 10, and 15 years following surgery versus nonsurgical, matched controls
For Women With Obesity, Risk for Breast Cancer Drops After Bariatric Surgery
Surgical treatment benefit greatest in women with baseline insulin levels above the median
Sleeve Gastrectomy Beneficial for Obese Kidney Transplant Candidates
SG was followed by active listing in 37 of 54 patients; 20 patients received KT during 20.9 months after SG
Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism
However, at one and five years after surgery, risk for venous thromboembolism and pulmonary embolism was lower
